Manas AI, an AI-driven drug discovery platform, has launched with $24.6 million in seed funding in a round co-led by General Catalyst and LinkedIn cofounder Reid Hoffman.
Greylock and other strategic investors participated in the round.
LinkedIn cofounder Reid Hoffman and Dr. Siddhartha Mukherjee, an oncologist, researcher and author, founded Manas AI.
WHAT IT DOES
Manas AI is a drug discovery...
